Actively Recruiting
Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment
Led by Albert Einstein College of Medicine · Updated on 2026-04-15
123
Participants Needed
1
Research Sites
220 weeks
Total Duration
On this page
Sponsors
A
Albert Einstein College of Medicine
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The proposed IMPOWR Research Center at Montefiore-Einstein (IMPOWR-ME) will create a multidisciplinary and synergistic program of research to test multimodal treatments that address both chronic pain and opioid use disorder. IMPOWR-ME will generate critical knowledge about the effectiveness, implementation, and cost effectiveness of providing Acceptance and Commitment Therapy and/or a care management smartphone app for individuals in primary care-based buprenorphine treatment. Patients with lived experience with chronic pain and/or opioid use disorder, patient and policy advocates, payors, and health system partners will be engaged in all stages of the research. IMPOWR-ME is well-positioned to become a long-lasting hub for stakeholder-engaged research with multidisciplinary senior and early stage investigators focused on reducing overdose through better treatments for OUD and CP.
CONDITIONS
Official Title
Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Proficient in English or Spanish
- Receiving buprenorphine treatment for opioid use disorder for at least 14 days with a stable dose
- Chronic pain with moderate or greater severity (score ≥ 4 on PEG scale)
- Comorbid psychiatric conditions and use of psychotropic medications allowed
You will not qualify if you...
- Acute psychiatric conditions preventing study participation (e.g., acute mania, active suicidality/homicidality, psychosis)
- Changes in psychotropic medications within 3 months prior to enrollment
- Chronic pain related to cancer
- Previous Acceptance and Commitment Therapy or similar therapy
- Started psychotherapy within the past 3 months
- Neurocognitive conditions preventing access to telehealth
- Current use of a smartphone health platform similar to the Valera app
- Unable or unwilling to provide signed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Montefiore Medical Center
The Bronx, New York, United States, 10461
Actively Recruiting
Research Team
H
Hector Perez, MD
CONTACT
J
Joanna Starrels, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here